CMS.gov, Medicare GLP-1 Bridge Program announcement Wegovy is FDA-approved for chronic weight management (BMI 30+, or 27+ with a weight-related comorbidity) and cardiovascular risk reduction in adults with established CVD it is not a diabetes drug, unlike Ozempic
But we have not won the war, Jess Winfrey, the Texas influencer, said in a recent post
However, patients with certain risk factors such as recent dose increases, significant gastrointestinal symptoms, or known gastroparesis may benefit from temporarily holding their medication based on individualized assessment by their healthcare team
The difference in effect size reflects the fundamental distinction between metabolic enhancement via dietary compounds and pharmacological appetite regulation
Developed for optimal absorption and bioavailability